Pulmonary targeted antibiotics in bronchiectasis; inhalers vs. nebulisers. A qualitative and quantitative assessment of patients’ attitudes

John Davison (Whitley Bay, United Kingdom), John Davison, Donna McEvoy, Gareth Davies, Richard Lee, Rapley Tim, Anthony De Soyza

Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Session: Possible phenotypes of bronchiectasis and exacerbations
Session type: Poster Discussion
Number: 1553
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
John Davison (Whitley Bay, United Kingdom), John Davison, Donna McEvoy, Gareth Davies, Richard Lee, Rapley Tim, Anthony De Soyza. Pulmonary targeted antibiotics in bronchiectasis; inhalers vs. nebulisers. A qualitative and quantitative assessment of patients’ attitudes. Eur Respir J 2016; 48: Suppl. 60, 1553

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Preference, satisfaction and critical errors with Genuair® and Breezhaler® in patients with COPD
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014


Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs)
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Validation of the ’test of the adherence to inhalers’ (TAI) for asthma and COPD patients
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Reproducibility of inhaler use and pulmonary drug deposition in COPD
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016


Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016

Comparison of asthma and COPD patients' perception of appropriate metered-dose inhaler technique with a questionnaire and supervision based reference standard
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Antibiotic treatment strategies in adults with bronchiectasis
Source: Eur Respir Mon 2011; 52: 211-222
Year: 2011


Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health
Year: 2015

Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016


Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with asthma
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Contraindications and precautions with inhalation therapy in COPD. Awareness or unawareness, a questionaire
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


Do correct steps using pMDI technique with spacer predict no exacerbations of Asthma or COPD?
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016


Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015


Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013


Observation of the knowledge and use of inhalers in children
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016


Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015

Patient needs and medication styles in COPD
Source: Eur Respir Rev 2005; 14: 89-92
Year: 2005